Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs
Top Cited Papers
Open Access
- 25 January 2014
- journal article
- Published by Taylor & Francis Ltd in Emerging Microbes & Infections
- Vol. 3 (1), 1-7
- https://doi.org/10.1038/emi.2014.88
Abstract
In light of the current outbreak of Ebola virus disease, there is an urgent need to develop effective therapeutics to treat Ebola infection, and drug repurposing screening is a potentially rapid ap...This publication has 32 references indexed in Scilit:
- A Systematic Screen of FDA-Approved Drugs for Inhibitors of Biological Threat AgentsPLOS ONE, 2013
- Digoxin Suppresses HIV-1 Replication by Altering Viral RNA ProcessingPLoS Pathogens, 2013
- Multiple Cationic Amphiphiles Induce a Niemann-Pick C Phenotype and Inhibit Ebola Virus Entry and InfectionPLOS ONE, 2013
- Identification of Small Molecules with Type I Interferon Inducing Properties by High-Throughput ScreeningPLOS ONE, 2012
- The NCGC Pharmaceutical Collection: A Comprehensive Resource of Clinically Approved Drugs Enabling Repurposing and Chemical GenomicsScience Translational Medicine, 2011
- A Grid Algorithm for High Throughput Fitting of Dose-Response Curve DataCurrent Chemical Genomics, 2010
- Cell adhesion-dependent membrane trafficking of a binding partner for the ebolavirus glycoprotein is a determinant of viral entryProceedings of the National Academy of Sciences of the United States of America, 2010
- An enzymatic virus-like particle assay for sensitive detection of virus entryJournal of Virological Methods, 2010
- Zaire Ebola virus entry into human dendritic cells is insensitive to cathepsin L inhibitionCellular Microbiology, 2010
- Cardiac Glycosides Inhibit p53 Synthesis by a Mechanism Relieved by Src or MAPK InhibitionCancer Research, 2009